Saudi Aramco balances competing priorities as IKTVA enters 6th year

Saudi Aramco is playing an active role in the diversification of the Saudi economy — ironically, away from a dependence on oil and its derivatives. (SPA)
Short Url
Updated 24 January 2022
Follow

Saudi Aramco balances competing priorities as IKTVA enters 6th year

  • New and existing energy sources need to act in parallel for a long time, says CEO

LONDON: The focal point of Saudi Aramco’s forthcoming In-Kingdom Total Value Add Forum will be the company’s initiative, launched in 2015, to further develop a local supply chain. 
In Aramco’s own words, the intention is to “transform and diversify the Kingdom’s economy through partnership and collaboration, creating high-skilled jobs for the Saudi population (and building) a resilient economy for the future.” 
The IKTVA program opens many opportunities for both companies and workers in Saudi Arabia, and reflects the objectives of the Kingdom’s Vision 2030 — but what of Aramco itself?
As the world’s leading crude oil supplier, with an output of some 10 million barrels per day, Aramco currently has a daily turnover of SR32.6 billion ($8.7 billion). That adds up to some $317.5 billion per annum, up from gross revenue of $205 billion and net revenues of $49 billion in the financial year 2020 — the last full year reported. 

With an income of such magnitude, Aramco would seemingly have little to worry about.
However, broader global issues require Aramco to come up with innovative strategies to overcome both present and future headwinds.
The 2021 United Nations Climate Change Conference, better known as COP26, articulated an “anti-oil” sentiment held by many countries, with a broad consensus to transition the global economy away from fossil fuels in favor of more environmentally friendly energy sources including solar, wind, tidal and geothermal. 
There is a shift, which began in earnest by Tesla and now includes legacy auto manufacturers such as VW, Volvo and Mercedes, from petrol/diesel engines to battery-powered electric vehicles. This trend is growing at an exponential pace, with Forbes reporting that almost 20 percent of cars purchased in China in the fourth quarter of 2021 were electric. This is likely the shape of things to come for the rest of the world.
These developments put Aramco in the spotlight as a giant of the carbon fuel sector, alongside a possible danger of becoming the world’s leading supplier of a gradually redundant commodity. 
However, the reality behind the headlines is that global oil demand is actually on an upward tangent, as the world emerges from an industrial dip caused by the two-year COVID-19 pandemic. 
According to a report from the US Energy Information Administration released on Jan. 11: “Rising economic activity and the easing of pandemic-related restrictions on other activities resulted in global oil consumption rising by 5.5 percent in 2021 from 2020.”
The same report goes on to state that with oil consumption outpacing production, the fourth quarter of 2021 saw significant increases in prices of the commodity, with Brent crude oil spot increasing from an average of $43 per barrel in the third quarter of 2020 to an average of $79 per barrel in the fourth quarter of 2021. 
Current oil prices are even higher, with the various grades of Arabian crude hovering between $87 and $89 per barrel.

Opinion

This section contains relevant reference points, placed in (Opinion field)

The EIA predicts that total world petroleum consumption of 96.9 million barrels per day in 2021 will slightly increase to 100.5 mbpd in 2022.  Is that level of demand sustainable? Aramco, for one, believes the answer is yes. 
“(Energy) alternatives are nowhere near ready to carry a big enough load, so new and existing energy sources will need to operate in parallel for a long time,” Aramco CEO Amin H. Nasser declared at the World Petroleum Council Congress, held in Houston in December 2021. 
Nasser went on to say that while “Aramco is committed to a net-zero economy … there are still no truly viable alternatives to conventional fuels in aviation, shipping, and even trucking.”
He added: “Oil and gas will be needed for decades to come, and accelerating the reduction in their emissions is a strategic and urgent necessity for climate goals to be met. We are not short of opportunities, such as producing lower carbon products like blue hydrogen and blue ammonia; developing more efficient and lower emission internal combustion engines; and making the Circular Carbon Economy that G20 world leaders endorsed last year a reality.”  
In short, Aramco seeks to maintain its dominant position in the global oil sector while aiming to emerge as a future leading producer of clean fuels — a two-pronged approach that is evident in several recent deals in both Europe and Asia.
With regards to oil supply, in the past fortnight Aramco acquired a range of assets from Poland’s state-owned energy corporation Orlen PKN, including a major oil refinery and hundreds of petrol stations, in a deal worth $288 million. A contract was also signed for Aramco to supply Orlen with 200-337,000 barrels of oil per day, adding more purchases to those agreed earlier. 
In terms of “new” energy, Aramco has also recently entered into agreements with two large South Korean entities — Korea Electric Power Corporation and the S-Oil Corporation — to conduct feasibility studies for the future supply of blue hydrogen, a petrol substitute with far lower carbon emissions.   
As Saudi Aramco balances these competing global priorities, it is simultaneously playing an active role in the diversification of the Saudi economy — ironically, away from a dependence on oil and its derivatives, and with an emphasis on small-to-medium sized enterprises as opposed to major conglomerates.
The company has a lot on its plate and the IKTVA Forum will no doubt offer a platform to further clarify its strategy and philosophy going forward.


AI’s shift toward proactive healthcare

Updated 05 February 2026
Follow

AI’s shift toward proactive healthcare

  • Experts reveal how AI is reducing burnout and streamlining workflows

JEDDAH: Artificial intelligence is increasingly moving from the margins of healthcare innovation into its operational core. Rather than replacing clinicians, AI is being deployed to address persistent challenges across health systems, from administrative overload and staff burnout to fragmented data and inefficient patient flow.

Speaking to Arab News, Abbes Seqqat, chief executive officer of Rain Stella Technologies, and Eric Turkington, chief product officer, discussed how AI is already transforming healthcare delivery — and why its impact is most meaningful when embedded directly into clinical workflows rather than treated as a standalone tool.

Seqqat describes AI’s role as accelerating a structural shift in healthcare delivery. “AI is accelerating the shift in healthcare from reactive to proactive care, because AI fundamentally helps detect, analyze and predict,” he said, noting that many health systems lack the resources to perform these tasks at scale.

Abbes Seqqat, chief executive officer of Rain Stella Technologies. (RST photo)

While AI use cases in healthcare are broad, Seqqat emphasized that the most effective applications today focus on operational and clinical fundamentals, including reducing administrative burden, identifying patient risks earlier, and capturing clinical data more reliably and in real time.

RST’s portfolio reflects this approach, spanning surgical data capture and workflow automation, cloud-based electronic medical records, and health information exchange. Across these systems, the common goal is improving data quality and usability so clinicians can spend less time managing information and more time delivering care.

According to Turkington, RST’s systems rely on a mix of established and emerging AI technologies.

RST's Equinox offers a streamlined workflow, minimizing redundant data entry, and also allows for seamless integration with other systems. (RST images)

“Across the portfolio, we are using a wide range of AI and predictive technologies, from voice technology to reliably capture clinician inputs, to large language models that analyze and act on collected data,” he said.

A key focus has been adapting AI to regional and clinical realities. Voice models, for example, have been trained on UAE and GCC accents and grounded in medical terminology to improve accuracy in real-world settings. RST also uses retrieval-augmented generation and multi-agent AI architectures, allowing different AI components to perform specialized tasks such as classifying surgical notes, identifying unusual events, or assisting with billing and coding, Turkington explained.

DID YOU KNOW?

• AI can detect, analyze, and predict patient risks faster than traditional methods.

• Systems like Equinox use voice input and predictive analytics to actively support clinical decisions.

• AI assistants provide real-time updates, automate documentation, and improve coordination in operating theaters.

One of the central concerns around AI adoption is whether it adds complexity to already demanding clinical roles. Seqqat argues the opposite should be the goal.
“For nurses and frontline staff, AI’s greatest contribution is removing the invisible administrative friction that leads to burnout,” Seqqat said.

In operating theaters, AI systems can replace manual coordination methods such as phone calls and whiteboards by providing real-time situational awareness. By automating updates, anticipating delays, and serving as an on-demand clinical notepad, AI reduces cognitive load and allows staff to remain focused on patient care, he explained.

RST’s voice-enabled assistant, Orva, is designed specifically for perioperative environments.

Orva captures live updates through voice input, enabling it to surface delays, flag bottlenecks, and prompt coordination between departments. (RST photo)

Turkington said it enables hands-free documentation and coordination, helping surgical teams manage schedules and resources more effectively.

By capturing live updates through voice input, Orva can surface delays, flag bottlenecks, and prompt coordination between departments. It also assists with documentation and coding, reducing errors and supporting more accurate reimbursement— an area where incomplete records often create downstream challenges.

Electronic medical records remain central to healthcare delivery, but Turkington noted that AI can move them beyond passive data repositories.

Eric Turkington, chief product officer of Rain Stella Technologies. (RST photo)

“We designed Equinox as an EMR that enables you to spend less time with the software and more time with patients,” Turkington said.

Through voice input, automated documentation from visual annotations, and AI-generated pre-visit summaries, the system can actively support clinicians rather than slow them down. Predictive analytics, such as identifying no-show risks or highlighting care gaps, further shift EMRs toward decision-support tools rather than administrative obligations.

Both executives stressed that AI’s effectiveness depends heavily on data access and quality. Seqqat pointed to interoperability as a prerequisite rather than an afterthought.
“AI is only as powerful as the data it can access,” he said, adding that fragmented records limit both clinical insight and system-wide learning.

Health information exchanges, such as RST’s Constellation platform, enable patient data to be viewed longitudinally across providers. AI can then assist with patient identity matching and population-level analysis, allowing trends and risks to be identified across large datasets.

Turkington shared an example from an operating theatre where AI helped prevent cascading delays. When a surgical case ran late, a nurse verbally updated Orva that the patient was ready to exit. The system alerted the recovery unit, analyzed schedule conflicts, and prompted management to reassign staff before delays affected subsequent procedures.

Opinion

This section contains relevant reference points, placed in (Opinion field)

By tagging the cause of the delay and feeding that data into predictive models, the system helped prevent similar issues in the future — without additional manual coordination.

According to Seqqat, the primary returns from AI adoption come from combining efficiency with financial accuracy. Streamlined workflows allow providers to treat more patients without compromising care, while improved documentation reduces revenue leakage.

Looking ahead, Seqqat sees AI becoming central to Saudi Arabia’s healthcare transformation. He described its role as advancing smart hospitals, predictive patient flow, and precision medicine aligned with Vision 2030 goals.
“The role of AI in Saudi Arabia’s healthcare sector is evolving from a supporting technology to a foundational pillar of the Kingdom’s Vision 2030 transformation. Over the next few years, we expect to see AI move into the realm of smart hospitals, where predictive analytics optimize patient flow and AI-driven precision medicine leverages the Saudi Genome Program to provide hyper-personalized care. By unifying national health data and automating complex administrative workflows, AI will enable a more proactive, value-based healthcare model that improves patient outcomes and operational efficiency across the country.”